Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02217865 · ClinicalTrials.gov registry record
Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 32
- Enrollment target
NCT02217865: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT02217865 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02217865 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The long-term goal of this research is to develop new tools to guide patients, caregivers, and clinicians in making individualized decisions regarding colorectal cancer (CRC) surveillance. As part of a Patient-Centered Outcomes Research Institute-funded contract, investigator will analyze surveillance data to determine the effectiveness of CRC surveillance and recurrence risk taking into account different patient and tumor characteristics; identify key issues about CRC surveillance important to patients, caregivers, and clinicians; and integrate the recurrence risk and patient priorities into a patient-centered, risk stratified surveillance strategy by creating an interactive decision aid for use by patients and clinicians. This protocol addresses a formative step in the creation of the interactive decision aid where patients' information needs and preferences are assessed regarding decisions about surveillance. The specific aims of this protocol are: Phase 1 - To interview patients and their caregivers to determine their concerns, preferences and key priorities regarding surveillance after curative resection of colorectal cancer, and Phase 2 - To refine the key priorities identified in phase 1 through focus groups and surveys with patients and caregivers.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Focus Groups
- BEHAVIORAL Interviews - Colorectal Cancer Participants
- BEHAVIORAL Interviews - Caregivers of Colorectal Cancer Participants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-07-16 |
| Est. Completion | 2022-01-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02217865
The ClinicalTrials.gov registry entry for NCT02217865 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaire is the first listed.
NCT02217865 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02217865 about?
NCT02217865 is a clinical study titled "Patient-Centered Risk Adjusted Surveillance After Curative Resection of Colorectal Cancer". The long-term goal of this research is to develop new tools to guide patients, caregivers, and clinicians in making individualized decisions regarding colorectal cancer (CRC) surveillance. As part of a Patient-Centered Outcomes Research Institute-funded contract, investigator will analyze surveillan...
What is the current status of trial NCT02217865?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2014-07-16. Estimated completion is 2022-01-13.
What interventions are being tested in trial NCT02217865?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Focus Groups (BEHAVIORAL), Interviews - Colorectal Cancer Participants (BEHAVIORAL), Interviews - Caregivers of Colorectal Cancer Participants (BEHAVIORAL).
Who is sponsoring clinical trial NCT02217865?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.